The Food and Drug Administration (FDA) is advising caution before prescribing the antibiotic clarithromycin (Biaxin) to patients with heart disease because of a potential increased risk of heart problems...

The common macrolide antibiotic, clarithromycin, has been linked to an increase in cardiac deaths, according to researchers at Statens Serum Institut’s Department of Epidemiology Research in Copenhagen. In...